BMO Capital lowered the firm’s price target on MediaAlpha (MAX) to $23 from $27 but keeps an Outperform rating on the shares. Pending the outcome of the FTC’s inquiry and potential fine regarding MAX’s Health segment, the firm estimates that MediaAlpha will be able to settle at an amount that does not require an equity capital raise, which if correct would act as a positive catalyst for the stock, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MAX:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue